calibration curve range [Bioanalytics]

posted by ritesh.korat.pharma – India, 2016-02-26 20:35 (3359 d 15:55 ago) – Posting: # 16032
Views: 8,638

Dear Ladi

To satisfy EMEA guideline which states that minimum two QC covered within Cmax of that particular period you can take following steps

Firstly monitor around 20% of first subject of the study. if Cmax of both periods of that subjects (at least 67% among them) will cross two QC than no need of additional QC and if its not cross than add one more QC between LQC and MQC. The all procedure must be incorporated in SOP prior to analysis

E.g. if you have to perform analysis of 100 subjects then you can monitor first twenty subjects among them

20% of 100 subjects is 20

if Cmax of both period in 14 (67% of 20) subjects out of that 20 subjects cross two QC level than no need of additional QC and if its not than add one more QC between LQC and MQC. so, in remaining subjects cmax cross two QC levels

Regards,
Ritesh Korat

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
153 visitors (0 registered, 153 guests [including 8 identified bots]).
Forum time: 13:30 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5